How can hepatitis C be prevented in the long term?
- 31 October 2007
- journal article
- research article
- Published by Elsevier BV in International Journal of Drug Policy
- Vol. 18 (5), 338-340
- https://doi.org/10.1016/j.drugpo.2007.06.001
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Global estimates of prevalence of HCV infection among injecting drug usersInternational Journal of Drug Policy, 2007
- High hepatitis C incidence in new injecting drug users: a policy failure?Australian and New Zealand Journal of Public Health, 2007
- Incidence and risk factors for hepatitis C seroconversion in injecting drug users in AustraliaAddiction, 2006
- Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort studyBMJ, 2004
- The power of positive devianceBMJ, 2004
- Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of FranceEpidemiology and Infection, 2004
- Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and RisksThe Journal of Infectious Diseases, 2002
- Sharing of drug preparation equipment as a risk factor for hepatitis CAmerican Journal of Public Health, 2001
- Methadone maintenance and hepatitis C virus infection among injecting drug usersAddiction, 1997
- Transmission of Hepatitis C Virus: Rates, Routes, and CofactorsEpidemiologic Reviews, 1996